• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    14.03 Down 1.41(9.13%) Jun 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:15.44
    Open:14.61
    Bid:13.65 x 100
    Ask:14.70 x 100
    1y Target Est:10.60
    Beta:0.95
    Earnings Date:Jul 30 - Aug 3 (Est.)
    Day's Range:13.61 - 14.91
    52wk Range:5.34 - 15.88
    Volume:10,070,683
    Avg Vol (3m):2,011,800
    Market Cap:1.21B
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    IMGNDown 9.13%1.21B
    PFEDown 0.20%212.38B
    RHHBYDown 0.43%N/A
    SGENUp 4.91%5.68B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.70
    Quarterly EPS Est (Jun-15) :-0.35
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback